On August 25, 2020, the Chinese Embassy in Korea donated 20,000 USD to IVI for vaccine research and development as well as efforts to advance international cooperation for vaccines against infectious diseases including COVID-19.
H.E. Xing Haiming, the Ambassador of China to Korea, visited IVI’s Headquarters to deliver the donation and meet with IVI Director General Jerome Kim.
The People’s Republic of China signed the Agreement on the Establishment of the International Vaccine Institute at the United Nations, becoming IVI’s 18th State Party in January 1997 at IVI’s founding. Since then, China has had a long history of research collaboration with IVI including a large project on typhoid fever in Hechi City, Guangxi Province.
Ambassador Xing said, “Viruses have no borders, and infectious diseases differentiates no races. Against the Corona19, which is still spreading around the world, the international community must cooperate more than ever before…IVI has long been working on the research, development, and dissemination of various infectious diseases vaccines and has achieved great results.”
Dr. Kim appreciated the Embassy’s donation, saying, “IVI can play an invaluable role in furthering China’s global health objectives by sharing IVI’s R&D expertise with Chinese vaccine manufacturers and by participating in multi-country clinical trials for COVID-19, securing WHO prequalification status for Chinese vaccines like human papilloma virus, hepatitis E vaccine and pneumococcal conjugate vaccine.”